T1	Chemical	0 13	Oral afatinib
T2	Chemical	16 24	Gilotrif
T3	Disease	112 152	non-small-cell lung cancer ( NSCLC ) who
T4	Disease	158 170	tumours with
T5	Limited_variation	176 237	exon 19 deletions or exon 21 ( L858R ) substitution mutations
R1	isEquivalentTo	Arg1:T1	Arg2:T2
R2	treats	Arg1:T1	Arg2:T3
R3	treats	Arg1:T1	Arg2:T4
R4	treats	Arg1:T1	Arg2:T5
R5	isEquivalentTo	Arg1:T2	Arg2:T1
R6	treats	Arg1:T2	Arg2:T3
R7	treats	Arg1:T2	Arg2:T4
R8	treats	Arg1:T2	Arg2:T5
R9	isAssociatedWith	Arg1:T3	Arg2:T2
R10	isAssociatedWith	Arg1:T3	Arg2:T4
R11	isAssociatedWith	Arg1:T3	Arg2:T5
R12	isAssociatedWith	Arg1:T4	Arg2:T1
R13	isAssociatedWith	Arg1:T4	Arg2:T2
R14	isAssociatedWith	Arg1:T4	Arg2:T3
R15	isAssociatedWith	Arg1:T4	Arg2:T5
R16	isAssociatedWith	Arg1:T5	Arg2:T1
R17	isAssociatedWith	Arg1:T5	Arg2:T2
R18	isAssociatedWith	Arg1:T5	Arg2:T3
R19	isAssociatedWith	Arg1:T5	Arg2:T4
